MSR101 Predicting Overall Survival of Immune-Checkpoint Inhibitors (ICIS): Which Distributions Are the Most Accurate? A Systematic Literature Review and Extrapolations of French Cost-Effectiveness Report Assessments
Abstract
Authors
A Juban A Gueye S Branchoux AF Gaudin F Colrat